Financing ·
Smith+Nephew announced a cash tender offer on September 8, 2026, to purchase up to $250 million of its outstanding…
SNNUFSmith & Nephew PLC
Smith+Nephew announced a cash tender offer on September 8, 2026, to purchase up to $250 million of its outstanding 2.032% Senior Notes due 2030 from registered holders. The company intends to use proceeds from a concurrent offering of new senior notes due 2036 to fund the repurchase, aiming to proactively manage its debt portfolio and extend the average maturity profile. The tender offer is conditional upon receiving sufficient gross proceeds from the new issuance. Pricing will be determined on September 15, 2026, with settlement expected by September 18, 2026. Smith+Nephew operates in the medical technology industry, manufacturing devices for orthopaedics, sports medicine, and wound management.